Regulatory Approval

Regulatory Approval

Eco Animal Health Group Plc

ECO Animal Health Group plc

ECO RECEIVES MARKETING AUTHORISATION FOR AIVLOSIN^® IN CANADA.

NOTIFICATION OF RESULTS

ECO is pleased to report that the Veterinary Drugs Directorate (VDD) of Health Canada has granted ECO a marketing authorisation for Aivlosin^® 625 mg/g water soluble granules for pigs.

This formulation of Aivlosin^® will be marketed for the treatment of ileitis (porcine proliferative enteropathy (PPE)), an enteric disease of pigs. Aivlosin^® water soluble granules dissolve readily in water providing a simple solution for the accurate and simultaneous treatment of large numbers of animals.

Health Canada’s approval is ECO’s first in North America and marks a very important step in the Company’s continuing development of Aivlosin as a global veterinary product. It further extends the marketing reach of Aivlosin^®, ECO’s patented macrolide antibiotic, which is used for the treatment of respiratory and enteric diseases in pigs and poultry. Canada is currently enjoying an increase in its pig population following consolidation among producers, which bodes well for ECO, which has established its own company in Canada to help ensure a successful launch.

Peter Lawrence, chairman of ECO said: “Following years of investment in regulatory applications in North America via our Princeton, New Jersey office, we are delighted to receive our first registration in this important continent. Canada and the USA represent more than one third of the world market for our products and this breakthrough will benefit our future profitable growth. We expect our first approval from the FDA in the USA in the near future. This approval, coupled with our existing approvals in other countries, will in effect give us the rights to sell Aivlosin around the world. This will be another important step in making ECO one of the most important global animal health companies”.

The Company will announce its Interim Results for the six months to 30 September 2011 on Monday 12 December 2011.

Contacts:	Â
		Peter Lawrence 020 8336 6190
ECO Animal Health Group plc		Marc Loomes 020 8447 8899
Â
Spiro Financial		Anthony Spiro 020 8336 6196
Â
Cenkos Securities plc		Stephen Keys 020 7397 8926
(Nominated Adviser)

ECO Animal Health Group plc is a leader in the development, registration and marketing of pharmaceutical products for animals. Our products for these global growth markets promote well-being. Our financial goals are achieved through the careful and responsible application of science to generate value for our shareholders.